Table 2. Adverse effects of osteoporosis drugs.
| Drug | Common adverse events | Notable rare adverse events | 
|---|---|---|
| Oral bisphosphonate | Hypocalcaemia Upper gastrointestinal effects (gastro-oesophageal reflux, erosive oesophagitis) | Osteonecrosis of the jaw* Atypical femoral fractures † | 
| Intravenous bisphosphonates | Hypocalcaemia Flu-like illness following infusion | Osteonecrosis of the jaw* Atypical femoral fractures † | 
| Denosumab | Hypocalcaemia Injection-site reactions Atraumatic vertebral fractures following discontinuatio | Osteonecrosis of the jaw* Atypical femoral fractures † | 
| Raloxifene | Hot flushes Venous thromboembolism | Stroke | 
| Teriparatide | Hypercalcaemia Injection-site reactions | Theoretical risk of osteosarcoma | 
| Romosozumab | Injection-site reactions | Possible increased risk of major adverse cardiovascular events (myocardial infarction, stroke) Osteonecrosis of the jaw* (few case reports) Atypical femoral fractures † (few case reports) | 
* Risk factors include dental extractions, implants, poorly fitting dentures, pre-existing dental disease, glucocorticoid use and smoking.
† Risk factors include rheumatoid arthritis, increased femoral bowing, thicker lateral cortices at the femoral shaft and Asian ethnicity.